DK4065134T3 - Oral indgivelse af jernsuccinat til anvendelse til behandling af jernmangel hos patienter med hjertesvigt - Google Patents
Oral indgivelse af jernsuccinat til anvendelse til behandling af jernmangel hos patienter med hjertesvigt Download PDFInfo
- Publication number
- DK4065134T3 DK4065134T3 DK20812152.5T DK20812152T DK4065134T3 DK 4065134 T3 DK4065134 T3 DK 4065134T3 DK 20812152 T DK20812152 T DK 20812152T DK 4065134 T3 DK4065134 T3 DK 4065134T3
- Authority
- DK
- Denmark
- Prior art keywords
- iron
- patients
- treatment
- oral administration
- heart failure
- Prior art date
Links
- 206010019280 Heart failures Diseases 0.000 title 1
- 206010022971 Iron Deficiencies Diseases 0.000 title 1
- MDXRFOWKIZPNTA-UHFFFAOYSA-L butanedioate;iron(2+) Chemical compound [Fe+2].[O-]C(=O)CCC([O-])=O MDXRFOWKIZPNTA-UHFFFAOYSA-L 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Inorganic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE1951352 | 2019-11-26 | ||
PCT/SE2020/051104 WO2021107835A1 (en) | 2019-11-26 | 2020-11-18 | Oral administration of iron succinate for use in treating iron deficiency in patients having heart failure |
Publications (1)
Publication Number | Publication Date |
---|---|
DK4065134T3 true DK4065134T3 (da) | 2024-01-22 |
Family
ID=73554483
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK20812152.5T DK4065134T3 (da) | 2019-11-26 | 2020-11-18 | Oral indgivelse af jernsuccinat til anvendelse til behandling af jernmangel hos patienter med hjertesvigt |
Country Status (7)
Country | Link |
---|---|
US (1) | US20220395530A1 (da) |
EP (1) | EP4065134B1 (da) |
DK (1) | DK4065134T3 (da) |
ES (1) | ES2968183T3 (da) |
FI (1) | FI4065134T3 (da) |
PL (1) | PL4065134T3 (da) |
WO (1) | WO2021107835A1 (da) |
-
2020
- 2020-11-18 EP EP20812152.5A patent/EP4065134B1/en active Active
- 2020-11-18 FI FIEP20812152.5T patent/FI4065134T3/fi active
- 2020-11-18 DK DK20812152.5T patent/DK4065134T3/da active
- 2020-11-18 US US17/770,084 patent/US20220395530A1/en active Pending
- 2020-11-18 WO PCT/SE2020/051104 patent/WO2021107835A1/en active Search and Examination
- 2020-11-18 ES ES20812152T patent/ES2968183T3/es active Active
- 2020-11-18 PL PL20812152.5T patent/PL4065134T3/pl unknown
Also Published As
Publication number | Publication date |
---|---|
US20220395530A1 (en) | 2022-12-15 |
WO2021107835A1 (en) | 2021-06-03 |
EP4065134A1 (en) | 2022-10-05 |
ES2968183T3 (es) | 2024-05-08 |
EP4065134B1 (en) | 2023-12-20 |
PL4065134T3 (pl) | 2024-03-04 |
FI4065134T3 (fi) | 2024-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2017514871A5 (da) | ||
EA201500934A1 (ru) | Кардио- и нефропротективная противодиабетическая терапия | |
DK3439660T3 (da) | Anvendelse af pimobendan til reduktion af hjertestørrelse og forsinkelse af udbruddet af kliniske symptomer hos patienter med asymptomatisk hjertesvigt på grund af mitralklapsygdom | |
DK3740182T3 (da) | Madras med sensormodul til patientpleje | |
DK3324994T3 (da) | Nx-1207 til brug i fremgangsmåder til mindskning af behovet for kirurgi hos patient, som lider af godartet prostatisk hyperplasi | |
DK3749308T3 (da) | Behandling af patienter med klassisk fabrys sygdom med migalastat | |
CY1121166T1 (el) | Ενωσεις για τη θεραπεια παχυσαρκιας και μεθοδοι χρησης αυτων | |
MA37455A1 (fr) | Utilisation d'un dérivé de pyrazole dans le traitement d'exacerbations aigues d'une maladie pulmonaire obstructive chronique | |
DK3833425T3 (da) | Medicinsk implantat i form af en omviklet manchet-elektrodeindretning | |
MX2018001720A (es) | Metodos de sedacion y formulacion parenteral para uso durante el tratamiento de cuidados criticos. | |
BR112015007592A2 (pt) | composições de enalapril | |
ZA202105111B (en) | Pharmaceutical composition for the treatment of pulmonary arterial hypertension | |
IL285921A (en) | Intravenous formulation including estrogens for the treatment of acute heart failure | |
IL283469A (en) | Inhalable preparations for use in the treatment of lung diseases | |
DK3476395T3 (da) | Injicerbar sammensætning omfattende fibroblaster til anvendelse i behandlingen af hjertesygdomme | |
DK3377176T3 (da) | Fremgangsmåde til behandling af patienter, der får administreret rivaroxaban sammen med verapamil | |
BR112018068960A2 (pt) | formulações de enalapril | |
DK3874995T3 (da) | Fremgangsmåde til at hjælpe bevægelseshæmmede med påklædning | |
DK3520786T3 (da) | Kombination af stoffer til anvendelse i regenerativ terapi til patienter med type 1 diabetes mellitus | |
SI3124048T1 (sl) | Sestavek za peroralno uporabo pri zdravljenju gastroezofagealne refluksne bolezni ali neugodja | |
DK3937948T3 (da) | Phytoecdysoner og derivater deraf til anvendelse i behandlingen af neuromuskulære sygdomme | |
DK4065134T3 (da) | Oral indgivelse af jernsuccinat til anvendelse til behandling af jernmangel hos patienter med hjertesvigt | |
PT3215143T (pt) | Combinação compreendendo espirulina e palmitoíletanolamida | |
MA50358A (fr) | Sémaglutide en thérapie médicale | |
IL288678A (en) | Treatment of heart failure in human subjects |